HOOKIPA Pharma HOOK

$ 2.02 0.0%

Quarterly report 2024-Q3
added 11-14-2024

HOOKIPA Pharma Balance Sheet 2011-2024 | HOOK

Annual Balance Sheet HOOKIPA Pharma

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-114 M	-108 M	-61.3 M	-137 M	-108 M	-44.2 M	-57.6 M	-	-	-	-	-	-
Long Term Debt	1.17 M	2.31 M	3.91 M	4.54 M	3.5 M	4.39 M	3.74 M	-	-	-	-	-	-
Long Term Debt Current	1.64 M	1.69 M	1.68 M	2 M	1.81 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	29.5 M	32.3 M	8.8 M	10.6 M	11.1 M	9.16 M	112 M	-	-	-	-	-	-
Total Current Liabilities	42 M	35.6 M	27.7 M	21.1 M	14.8 M	-	-	-	-	-	-	-	-
Total Liabilities	71.5 M	67.9 M	36.5 M	31.7 M	25.8 M	23.9 M	116 M	-	-	-	-	-	-
Deferred Revenue	14.6 M	15.7 M	5.54 M	4.63 M	4.32 M	7.45 M	725 K	-	-	-	-	-	-
Retained Earnings	-369 M	-288 M	-223 M	-147 M	-103 M	-60 M	-43.7 M	-	-	-	-	-	-
Total Assets	161 M	170 M	126 M	188 M	144 M	68.3 M	73.7 M	-	-	-	-	-	-
Cash and Cash Equivalents	117 M	112 M	66.9 M	143 M	113 M	48.6 M	61.4 M	-	-	-	-	-	-
Book Value	89.9 M	103 M	89.6 M	156 M	118 M	44.4 M	-42.7 M	-	-	-	-	-	-
Total Shareholders Equity	89.9 M	103 M	89.6 M	156 M	118 M	-60.4 M	-42.7 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet HOOKIPA Pharma

	2024-Q3	2024-Q2	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	1.62 M	3.39 M	1.12 M	1.16 M	2.3 M	2.31 M	2.61 M	2.79 M	5.95 M	3.91 M	6.21 M	6.36 M	300 K	6.56 M	300 K	300 K	300 K	7.3 M	300 K	300 K	460 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	9.36 M	11.1 M	28.4 M	32.5 M	35.4 M	32.3 M	12.1 M	13 M	16.6 M	8.8 M	7.45 M	6.35 M	9.77 M	10.6 M	10.6 M	10.6 M	10.6 M	11.1 M	11.1 M	11.1 M	11.1 M	9.16 M	9.16 M	9.16 M	9.16 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	37.9 M	39 M	69 M	78.8 M	79.6 M	67.9 M	38.2 M	40.3 M	47.8 M	36.5 M	34.1 M	40.2 M	29.9 M	31.7 M	31.7 M	31.7 M	31.7 M	25.8 M	25.8 M	25.8 M	25.8 M	23.9 M	23.9 M	23.9 M	23.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	5.33 M	4.1 M	16.1 M	19.7 M	19 M	15.7 M	7.52 M	9.83 M	10.7 M	5.54 M	2.37 M	3.02 M	3.22 M	3.75 M	3.75 M	3.75 M	3.75 M	3.59 M	3.59 M	3.59 M	3.59 M	6.62 M	6.62 M	6.62 M	6.62 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-388 M	-374 M	-344 M	-325 M	-307 M	-288 M	-275 M	-257 M	-241 M	-223 M	-202 M	-181 M	-164 M	-147 M	-147 M	-147 M	-147 M	-103 M	-103 M	-103 M	-103 M	-60 M	-60 M	-60 M	-60 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	110 M	125 M	164 M	191 M	163 M	170 M	152 M	172 M	196 M	126 M	142 M	166 M	170 M	188 M	188 M	188 M	188 M	144 M	144 M	144 M	144 M	68.3 M	68.3 M	68.3 M	68.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	59.8 M	77.2 M	108 M	136 M	110 M	112 M	101 M	119 M	142 M	65.9 M	82.7 M	103 M	128 M	143 M	143 M	143 M	143 M	113 M	113 M	113 M	113 M	48.6 M	48.6 M	48.6 M	48.6 M	61.4 M	-	-	-	13.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	71.8 M	86.1 M	95.1 M	112 M	83.5 M	103 M	113 M	132 M	148 M	89.6 M	108 M	126 M	140 M	156 M	156 M	156 M	156 M	118 M	118 M	118 M	118 M	44.4 M	44.4 M	44.4 M	44.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	71.8 M	86.1 M	95.1 M	112 M	83.5 M	103 M	113 M	132 M	148 M	89.6 M	108 M	126 M	140 M	156 M	156 M	156 M	156 M	118 M	118 M	118 M	118 M	-60.4 M	-60.4 M	-60.4 M	-60.4 M	-42.7 M	-	-	-	-32.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency